Last week Pfizer published interim trial results for its experimental Covid-19 antiviral pill, Paxlovid, which the company said reduced the chance of hospitalization or death for some adults by almost 90 per cent. The US pharmaceutical giant’s analysis included 1,219 adults who had been diagnosed with mild to moderate Covid-19 and who had at least […] The post Facebook comment sections rife with misinformation following Pfizer’s Covid-19 antiviral pill announcement appeared first on Fir...
